回到网站

Make COVID-19 Detection Faster,

More Accurate and More Convenient

by AIAM

As the outbreak of pneumonia caused by COVID-19 continues, countries have begun to develop virus detection reagents. At present, the detection methods are mainly nucleic acid detection and antibody detection. The reason why many countries began to carry out antibody detection is that after half a year of virus battle, the advantage of nucleic acid detection is that it has high accuracy and is not affected by the human immune system; the disadvantage is that it has high requirements for laboratory environment, testing personnel and instruments. At the same time, the high requirements also make the detection speed relatively slow, and it is difficult to adapt to a large-scale screening in the short term. The antibody detection method is similar to the well-known pregnancy test rod, which requires the patient to drip a drop of blood onto the test box and wait a few minutes. If a red line appears, it means that the antibody has been detected, which indicates that it has been infected. The operation is simple and convenient, the test results can be obtained as fast as 3 minutes, which reduces the exposure risk of medical staff and can meet the needs of hospital testing and social screening. Antibody detection and nucleic acid detection have become double insurance for diagnosis and screening of COVID-19.

For some COVID-19 antibody detection kits on the market are prone to false negative due to the low amount of antibodies when testing some patients with patients with weakened immune functions. At the beginning of SARS-CoV-2 infection, the content of pathogen antigen is also low, and there is also the problem of missed detection. The SARS-CoV-2 Antibody Detection Kit developed by Asia Institute of Advanced Medicine (AIAM) in cooperation with Abbott adopts Nano-gold technology. The formation of antibody-Nano-gold covalent bond conjugate takes only 3 minutes, the conjugate is stable, the detection sensitivity is high, no PH titration operation is required, and the detection is convenient. Even if the sample is diluted 20,000 times and operated by personnel without professional and systematic training, accurate and true results can still be obtained. This product has received the European Union’s CE certification. The portable kit developed jointly by AIAM and Abbott was authorized by the U.S Fond and Drug Administration (FDA) on March 28.

The SARS-CoV-2 Antibody Detection Kit developed by Asia Institute of Advanced Medicine (AIAM) in cooperation with Abbott adopts Nano-gold technology. The formation of antibody-Nano-gold covalent bond conjugate takes only 3 minutes, the conjugate is stable, the detection sensitivity is high, no PH titration operation is required, and the detection is convenient. Even if the sample is diluted 20,000 times and operated by personnel without professional and systematic training, accurate and true results can still be obtained. This product has received the European Union’s CE certification. The portable kit developed jointly by AIAM and Abbott was authorized by the U.S Fond and Drug Administration (FDA) on March 28.

所有文章
×

快要完成了!

我们刚刚发给你了一封邮件。 请点击邮件中的链接确认你的订阅。

好的